These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6423805)
1. Effect of coadministration of uracil on the toxicity of tegafur. Yamamoto J; Haruno A; Yoshimura Y; Unemi N; Kunimune Y; Yamashita K; Morita K J Pharm Sci; 1984 Feb; 73(2):212-4. PubMed ID: 6423805 [TBL] [Abstract][Full Text] [Related]
2. [Effect of uracil on the both reactions, 5-fluorouracil degradation into 2-fluoro-beta-alanine and 5-fluorouracil splitting from tegafur in human tumor]. Kono A; Hara Y; Furusawa M Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2663-5. PubMed ID: 2505686 [No Abstract] [Full Text] [Related]
3. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil. Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578 [TBL] [Abstract][Full Text] [Related]
4. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats. Kawaguchi Y; Nagayama S; Masuda H; Yasuda A Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982 [TBL] [Abstract][Full Text] [Related]
5. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents. Fujii S; Kitano S; Ikenaka K; Shirasaka T Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats]. Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216 [TBL] [Abstract][Full Text] [Related]
7. Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil. Hoff PM; Lassere Y; Pazdur R Drugs; 1999; 58 Suppl 3():77-83. PubMed ID: 10711845 [TBL] [Abstract][Full Text] [Related]
8. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil]. Shirasaka T; Shimamoto Y; Kato T; Fukushima M Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831 [TBL] [Abstract][Full Text] [Related]
9. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735 [TBL] [Abstract][Full Text] [Related]
10. Neurotoxic effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs. Yamashita K; Yada H; Ariyoshi T J Toxicol Sci; 2004 May; 29(2):155-66. PubMed ID: 15206584 [TBL] [Abstract][Full Text] [Related]
11. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system. Toide K; Unemi N; Segawa T Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907 [TBL] [Abstract][Full Text] [Related]
12. [Clinical experiences with UFD-1]. Furue H Gan To Kagaku Ryoho; 1982 Apr; 9(4):672-4. PubMed ID: 6820905 [TBL] [Abstract][Full Text] [Related]
13. In vivo 19F NMR comparative study of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and an FT-uracil coadministration system in mouse tumors. Kanazawa Y; Kurogi S; Shinohara S; Noda Y; Masuda K Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):774-8. PubMed ID: 8020119 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the actions of 5-fluorouracil and ftorafur in Escherichia coli. Saunders PP; Chao LY Antimicrob Agents Chemother; 1977 Mar; 11(3):451-4. PubMed ID: 324392 [TBL] [Abstract][Full Text] [Related]
15. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil. Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250 [TBL] [Abstract][Full Text] [Related]
16. Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Akiba T; Okeda R; Tajima T Acta Neuropathol; 1996 Jul; 92(1):8-13. PubMed ID: 8811119 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience. Lin JK; Wang WS; Hsieh RK; Hsu TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM Jpn J Clin Oncol; 2000 Nov; 30(11):510-4. PubMed ID: 11155922 [TBL] [Abstract][Full Text] [Related]
18. High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur. Marunaka T; Umeno Y; Yoshida K; Nagamachi M; Minami Y; Fujii S J Pharm Sci; 1980 Nov; 69(11):1296-300. PubMed ID: 6778988 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients]. Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Toide H; Akiyoshi H; Minato Y; Okuda H; Fujii S Gan; 1977 Oct; 68(5):553-60. PubMed ID: 22472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]